Cipla P& L

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

11/19/2019 Cipla | Standalone Profit & Loss account > Pharmaceuticals > Standalone Profit & Loss account

account of Cipla - BSE: 500087, NSE: CIPLA

This data can be easily copy pasted into a Microsoft Excel sheet PRINT
Cipla Previous Years »
Standalone Profit & Loss account ------------------- in Rs. Cr. -------------------
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15

12 mths 12 mths 12 mths 12 mths 12 mths

INCOME
Revenue From Operations [Gross] 11,974.92 11,004.44 10,637.08 11,873.46 9,831.88
Less: Excise/Sevice Tax/Other Levies 0.00 54.91 206.09 0.00 92.94
Revenue From Operations [Net] 11,974.92 10,949.53 10,430.99 11,873.46 9,738.94
Other Operating Revenues 399.09 440.37 337.50 244.26 392.84
Total Operating Revenues 12,374.01 11,389.90 10,768.49 12,117.72 10,131.78
Other Income 577.52 334.88 129.85 280.30 147.91
Total Revenue 12,951.53 11,724.78 10,898.34 12,398.02 10,279.69
EXPENSES
Cost Of Materials Consumed 3,112.25 3,303.31 2,956.04 3,633.34 3,426.74
Purchase Of Stock-In Trade 1,259.21 1,064.23 1,128.99 1,037.56 903.41
Operating And Direct Expenses 0.00 475.13 443.37 0.00 0.00
Changes In Inventories Of FG,WIP And
136.70 -212.05 56.27 228.35 -349.05
Stock-In Trade
Employee Benefit Expenses 1,839.84 1,785.94 1,728.97 1,778.56 1,505.58
Finance Costs 16.97 11.90 39.20 147.07 136.05
Depreciation And Amortisation Expenses 569.72 529.61 499.97 442.69 433.20
Other Expenses 3,524.01 2,777.79 2,858.59 3,386.48 2,683.79
Total Expenses 10,458.70 9,735.86 9,711.40 10,654.05 8,739.72
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15

12 mths 12 mths 12 mths 12 mths 12 mths

Profit/Loss Before Exceptional,


2,492.83 1,988.92 1,186.94 1,743.97 1,539.97
ExtraOrdinary Items And Tax
Exceptional Items 0.00 -77.52 0.00 0.00 0.00
Profit/Loss Before Tax 2,492.83 1,911.40 1,186.94 1,743.97 1,539.97
Tax Expenses-Continued Operations
Current Tax 576.43 431.33 311.06 356.64 318.78
Deferred Tax 27.99 11.55 -99.06 -74.97 40.10
Total Tax Expenses 604.42 442.88 212.00 281.67 358.88
Profit/Loss After Tax And Before
1,888.41 1,468.52 974.94 1,462.30 1,181.09
ExtraOrdinary Items
Profit/Loss From Continuing
1,888.41 1,468.52 974.94 1,462.30 1,181.09
Operations
Profit/Loss For The Period 1,888.41 1,468.52 974.94 1,462.30 1,181.09
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15

12 mths 12 mths 12 mths 12 mths 12 mths

OTHER ADDITIONAL INFORMATION


EARNINGS PER SHARE
Basic EPS (Rs.) 23.45 18.25 12.13 18.21 14.71
Diluted EPS (Rs.) 23.41 18.22 12.11 18.16 14.66
VALUE OF IMPORTED AND INDIGENIOUS RAW
MATERIALS
Imported Raw Materials 0.00 0.00 0.00 0.00 1,523.87
https://www.moneycontrol.com/stocks/company_info/print_main.php 1/2
11/19/2019 Cipla | Standalone Profit & Loss account > Pharmaceuticals > Standalone Profit & Loss account of Cipla - BSE: 500087, NSE: CIPLA

Indigenous Raw Materials 0.00 0.00 0.00 0.00 2,004.38


STORES, SPARES AND LOOSE TOOLS
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend 281.97 160.94 160.87 180.92 160.59
Tax On Dividend 0.00 28.33 32.71 0.00 32.69
Equity Dividend Rate (%) 150.00 150.00 100.00 100.00 100.00

Source : Dion Global Solutions Limited

https://www.moneycontrol.com/stocks/company_info/print_main.php 2/2

You might also like